Thiolactomycin analogues as potential anti-Toxoplasma gondii agents.

[1]  B. Striepen,et al.  Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii , 2006, Proceedings of the National Academy of Sciences.

[2]  E. Maréchal,et al.  Toxoplasma gondii acyl-lipid metabolism: de novo synthesis from apicoplast-generated fatty acids versus scavenging of host cell precursors. , 2006, The Biochemical journal.

[3]  I. Gilbert,et al.  Analogues of thiolactomycin as potential antimalarial agents. , 2005, Journal of medicinal chemistry.

[4]  C. Roberts,et al.  Triazine Inhibits Toxoplasma gondii Tachyzoites In Vitro and In Vivo , 2005, Antimicrobial Agents and Chemotherapy.

[5]  Jie J. Zheng,et al.  The structural biology of type II fatty acid biosynthesis. , 2005, Annual review of biochemistry.

[6]  T. Ramya,et al.  'FAS't inhibition of malaria. , 2004, The Biochemical journal.

[7]  Colin Berry,et al.  Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents. , 2004, Bioorganic & medicinal chemistry.

[8]  S. Ralph,et al.  A Type II Pathway for Fatty Acid Biosynthesis Presents Drug Targets in Plasmodium falciparum , 2003, Antimicrobial Agents and Chemotherapy.

[9]  L. Sibley,et al.  Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. , 2002, Journal of cell science.

[10]  D. Soldati,et al.  Toxoplasmosis: a persisting challenge. , 2001, Trends in parasitology.

[11]  R. Lyons,et al.  Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. , 2001, International journal for parasitology.

[12]  D. Roos,et al.  Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Palmer,et al.  A Plastid of Probable Green Algal Origin in Apicomplexan Parasites , 1997, Science.

[14]  B. Luft,et al.  Toxoplasmic encephalitis in AIDS. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  C. Rock,et al.  Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. , 1989, The Journal of biological chemistry.

[16]  J. H. Law,et al.  Role of lipophorin in lipid transport to the insect egg. , 1988, The Journal of biological chemistry.

[17]  H. Haverkos.  Assessment of therapy for toxoplasma encephalitis. The TE Study Group. , 1987, The American journal of medicine.

[18]  H. Okazaki,et al.  THIOLACTOMYCIN, A NEW ANTIBIOTIC , 1982 .

[19]  E. Pfefferkorn,et al.  Specific labeling of intracellular Toxoplasma gondii with uracil. , 1977, The Journal of protozoology.

[20]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[21]  G. McFadden,et al.  Fatty acid biosynthesis as a drug target in apicomplexan parasites. , 2007, Current drug targets.

[22]  S. Clarke,et al.  Fatty Acid Synthesis and its Regulation , 2004 .

[23]  H. Okazaki,et al.  Thiolactomycin, a new antibiotic. I. Taxonomy of the producing organism, fermentation and biological properties. , 1982, The Journal of antibiotics.